Syneron Medical Ltd (ELOS) Misses Q4 EPS by 1c
Syneron Medical Ltd (NASDAQ: ELOS) reported Q4 EPS of $0.03, $0.01 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $61 million versus the consensus estimate of $62.52 million.
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Nomura Securities Upgrades ASML Inc. (ASML) to Buy; Revenue Outlook Underestimated
- Syneron to Host Investor Meeting on May 22, 2012
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
